MwanzoDMYD-B • STO
add
Diamyd Medical AB
Bei iliyotangulia
kr 11.00
Bei za siku
kr 11.12 - kr 11.44
Bei za mwaka
kr 7.50 - kr 19.50
Thamani ya kampuni katika soko
1.51B SEK
Wastani wa hisa zilizouzwa
elfu 323.76
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Mei 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 47.17M | 17.45% |
Mapato halisi | -43.88M | -9.50% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | — | — |
EBITDA | -46.46M | -17.32% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Mei 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 319.26M | 96.61% |
Jumla ya mali | 400.07M | 61.19% |
Jumla ya dhima | 75.40M | 42.93% |
Jumla ya hisa | 324.67M | — |
hisa zilizosalia | 137.50M | — |
Uwiano wa bei na thamani | 4.66 | — |
Faida inayotokana na mali | -41.41% | — |
Faida inayotokana mtaji | -55.16% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Mei 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -43.88M | -9.50% |
Pesa kutokana na shughuli | -43.50M | -18.29% |
Pesa kutokana na uwekezaji | -4.25M | 89.37% |
Pesa kutokana na ufadhili | 258.96M | 321.52% |
Mabadiliko halisi ya pesa taslimu | 215.51M | 1,626.72% |
Mtiririko huru wa pesa | -31.45M | -36.16% |
Kuhusu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Tovuti
Wafanyakazi
30
